干细胞移植在肾脏疾病中的应用

黄丹琳,易著文

中国当代儿科杂志 ›› 2012, Vol. 14 ›› Issue (2) : 154-160.

PDF(969 KB)
PDF(969 KB)
中国当代儿科杂志 ›› 2012, Vol. 14 ›› Issue (2) : 154-160.
综述

干细胞移植在肾脏疾病中的应用

  • 黄丹琳,易著文
作者信息 +

Application of stem cell transplantation in kidney diseases

  • HUANG Dan-Lin, YI Zhu-Wen
Author information +
文章历史 +

摘要

该文总结干细胞移植在肾脏损伤修复中的治疗证据,着重讨论干细胞种类的选择、移植方法的选择、干细胞抵达肾脏的可能机制和它起效的可能机制。脐带间充质干细胞的应用具有广阔的前景,但细胞移植的途径和最佳剂量仍有待进一步研究。干细胞抵达肾脏的机制可能和靶部位表达和释放趋化干细胞的因子有关,而干细胞的旁分泌和内分泌功能可能是它发挥作用的主要的机制。关于干细胞移植治疗肾脏疾病还有许多问题有待解决,但是干细胞移植仍是急慢性肾脏疾病的治疗中一个充满前景和希望的治疗策略。

Abstract

This paper summarizes the current literature on the potential therapeutic role of stem cell transplantation for kidney injury and repair and focuses on the choice of types of stem cells, the method of transplantation, and the mechanisms of stem cell homing to injured renal tissues and its protective effects. The application of umbilical cord mesenchymal stem cells (UC-MSCs) shows wide prospects, but the approach and optimal dose of cell transplantation are under intensive investigation. Signals that regulate stem cell homing to injured renal tissues may be related to chemokines or factors released in the target site. Several studies have pointed out that paracrine and endocrine of stem cells are the most likely mechanism of action in the injured nephron. Many questions remain unanswered but stem cell-based therapy is a promising new strategy for acute and chronic kidney diseases.

关键词

干细胞移植 / 肾脏疾病

Key words

Stem cell transplantation / Kidney disease

引用本文

导出引用
黄丹琳,易著文. 干细胞移植在肾脏疾病中的应用[J]. 中国当代儿科杂志. 2012, 14(2): 154-160
HUANG Dan-Lin, YI Zhu-Wen. Application of stem cell transplantation in kidney diseases[J]. Chinese Journal of Contemporary Pediatrics. 2012, 14(2): 154-160
中图分类号: R725   

参考文献

[1]Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, et al. Embryonic stem cell lines derived from human blastocysts[J]. Science, 1998, 282(5391): 1145-1147.

[2]Lin F, Moran A, Igarashi P. Intrarenal cells, not bone marrow-derived cells, are the major source for regeneration in postischemic kidney[J]. J Clin Invest, 2005, 115(7): 1756-1764.

[3]Bussolati B, Bruno S, Grange C, Buttiglieri S, Chiara DM, Cantino D, et al. Isolation of renal progenitor cells from adult human kidney[J]. Am J Pathol, 2005, 166(2): 545-555.

[4]Lazzeri E, Crescioli C, Ronconi E, Mazzinghi B, Sagrinati C, Netti GS, et al. Regenerative potential of embryonic renal multipotent progenitors in acute renal failure[J]. J Am Soc Nephrol, 2007, 18(12): 3128-3138.

[5]Mazzinghi B, Ronconi E, Lazzeri E, Sagrinati C, Ballerini L, Angelotti ML, et al. Essential but differential role for CXCR4 and CXCR7 in the therapeutic homing of human renal progenitor cells[J]. J Exp Med, 2008, 205(2): 479-490.

[6]Oliver JA, Barasch J, Yang J, Herzlinger D, Al-Awqati Q. Metanephric mesenchyme contains embryonic renal stem cells[J]. Am J Physiol Renal Physiol, 2002, 283(4): F799F809.

[7]Levashova ZB, Plisov SY, Perantoni AO. Conditionally immortalized cell line of inducible metanephric mesenchyme[J]. Kidney Int, 2003, 63(6): 2075-2087.

[8]刘喜红,易著文,陈丹,何小解,莫双红.胚胎后肾间充质细胞移植对急性肾小管坏死肾小管上皮细胞凋亡和增生的影响[J].中华儿科杂志,2007,(11):863-864.
[9]焦玉清,易著文,何小解,刘喜红,何庆南,黄丹琳.后肾间充质细胞移植治疗大鼠慢性阿霉素肾病[J].中华肾脏病杂志,2009,25(12):930-935.
[10]Lin F, Moran A, Igarashi P. Intrarenal cells, not bone marrow-derived cells, are the major source for regeneration in postischemic kidney[J]. J Clin Invest, 2005, 115(7): 1756-1764.

[11]Morigi M, Imberti B, Zoja C, Corna D, Tomasoni S, Abbate M, et al. Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure[J]. J Am Soc Nephrol, 2004, 15(7): 1794-1804.

[12]杨焕丹,董晨,关凤军,高莉莉,赵彤,丰炳峰.骨髓间充质干细胞移植对嘌呤霉素氨基核苷肾病大鼠足细胞修复作用的研究[J].中国当代儿科杂志,2010,12(6):483-487.

[13]Imberti B, Morigi M, Tomasoni S, Rota C, Corna D, Longaretti L, et al. Insulin-like growth factor-1 sustains stem cell mediated renal repair[J]. J Am Soc Nephrol, 2007, 18(11): 2921-2928.

[14]Bi B, Schmitt R, Israilova M, Nishio H, Cantley LG. Stromal cells protect against acute tubular injury via an endocrine effect[J]. J Am Soc Nephrol, 2007, 18(9): 2486-2496.

[15]殷莉波,赵文秀,尹震宇,杨中萌,张琼,王效民.人脂肪间充质干细胞的分离培养及其鉴定[J].中国组织工程研究与临床康复,2010,14(32):5997-6000.

[16]毕薇薇,黄若洋,刘洋.人胎儿肝脏间充质干细胞的体外培养及生物学特性研究[J].中国医药生物技术,2010,5(4):277-280.

[17]Erices A, Conget P, Minguell JJ. Mesenchymal progenitor cells in human umbilical cord blood[J]. Br J Haematol, 2000, 109(1): 235-242.

[18]Lu LL, Liu YJ, Yang SG, Zhao QJ, Wang X, Gong W, et al. Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials[J]. Haematologica, 2006, 91(8): 1017-1026.

[19]颜小华,陈晓.脐血间充质干细胞静脉移植治疗新生大鼠缺氧缺血性脑损伤[J].中国新生儿科杂志,2006,(3):158-161.

[20]Caballero M, Reed CR, Madan G, van AJA. Osteoinduction in umbilical cord-and palate periosteumderived mesenchymal stem cells[J]. Ann Plast Surg, 2010, 64(5): 605-609.

[21]Zhang HT, Chen H, Zhao H, Dai YW, Xu RX. Neural stem cells differentiation ability of human umbilical cord mesenchymal stromal cells is not altered by cryopreservation[J]. Neurosci Lett, 2011, 487(1): 118-122.

[22]蔡馥丞,黄亚玲,熊念,鲁娜,钟严艳,王涛.脐带间充质干细胞植入脑缺氧缺血模型仔鼠存活、增殖及分化[J].实用儿科临床杂志,2009,24(8):618-621.

[23]Cao H, Qian H, Xu W, Zhu W, Zhang X, Chen Y, et al. Mesenchymal stem cells derived from human umbilical cord ameliorate ischemia/reperfusion-induced acute renal failure in rats[J]. Biotechnol Lett, 2010, 32(5): 725732.

[24]Chen Y, Qian H, Zhu W, Zhang X, Yan Y, Ye S, et al. Hepatocyte growth factor modification promotes the amelioration effects of human umbilical cord mesenchymal stem cells on rat acute kidney injury[J]. Stem Cells Dev, 2011, 20(1): 103-113.

[25]Gu Z, Akiyama K, Ma X, Zhang H, Feng X, Yao G, et al. Transplantation of umbilical cord mesenchymal stem cells alleviates lupus nephritis in MRL/lpr mice[J]. Lupus, 2010, 19(13): 1502-1514.

[26]Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors[J]. Cell, 2006, 126(4): 663-676.

[27]Aoi T, Yae K, Nakagawa M, Ichisaka T, Okita K, Takahashi K, et al. Generation of pluripotent stem cells from adult mouse liver and stomach cells[J]. Science, 2008, 321(5889): 699-702.

[28]Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors[J]. Cell, 2007, 131(5): 861-872.

[29]Stadtfeld M, Brennand K, Hochedlinger K. Reprogramming of pancreatic beta cells into induced pluripotent stem cells[J]. Curr Biol, 2008, 18(12): 890-894.

[30]Loh YH, Agarwal S, Park IH, Urbach A, Huo H, Heffner GC, et al. Generation of induced pluripotent stem cells from human blood[J]. Blood, 2009, 113(22): 5476-5479.

[31]Zhang J, Wilson GF, Soerens AG, Koonce CH, Yu J, Palecek SP, et al. Functional cardiomyocytes derived from human induced pluripotent stem cells[J]. Circ Res, 2009, 104(4): e30-e41.

[32]Karumbayaram S, Novitch BG, Patterson M, Umbach JA, Richter L, Lindgren A, et al. Directed differentiation of human-induced pluripotent stem cells generates active motor neurons[J]. Stem Cells, 2009, 27(4): 806-811.

[33]Choi KD, Yu J, Smuga-Otto K, Salvagiotto G, Rehrauer W, Vodyanik M, et al. Hematopoietic and endothelial differentiation of human induced pluripotent stem cells[J]. Stem Cells, 2009, 27(3): 559567.

[34]Hirami Y, Osakada F, Takahashi K, Okita K, Yamanaka S, Ikeda H, et al. Generation of retinal cells from mouse and human induced pluripotent stem cells[J]. Neurosci Lett, 2009, 458(3): 126-131.

[35]Rossant J. Stem cells: the magic brew[J]. Nature, 2007, 448(7151): 260-262.

[36]Kunter U, Rong S, Boor P, Eitner F, MullerNewen G, Djuric Z, et al. Mesenchymal stem cells prevent progressive experimental renal failure but maldifferentiate into glomerular adipocytes[J]. J Am Soc Nephrol, 2007, 18(6): 1754-1764.

[37]Morigi M, Introna M, Imberti B, Corna D, Abbate M, Rota C, et al. Human bone marrow mesenchymal stem cells accelerate recovery of acute renal injury and prolong survival in mice[J]. Stem Cells, 2008, 26(8): 2075-2082.

[38]Quimby JM, Webb TL, Gibbons DS, Dow SW. Evaluation of intrarenal mesenchymal stem cell injection for treatment of chronic kidney disease in cats: a pilot study[J]. J Feline Med Surg, 2011,13(6): 418-426.

[39]Rogers SA, Hammerman MR. Transplantation of rat metanephroi into mice[J]. Am J Physiol Regul Integr Comp Physiol, 2001, 280(6): R1865-R1869.

[40]陈丹,易著文,刘喜红,何庆南,黄丹琳,吴小川,等.胚胎后肾间充质细胞肾包膜下移植对急性肾小管坏死大鼠的保护作用[J].中华肾脏病杂志,2009,25(3):191-197.

[41]Asanuma H, Vanderbrink BA, Campbell MT, Hile KL, Zhang H, Meldrum DR, et al. Arterially delivered mesenchymal stem cells prevent obstruction-induced renal fibrosis[J]. J Surg Res, 2011,168(1):e51-e59.

[42]董兴刚,冯健,俞志满,过源.骨髓间充质干细胞肾动脉注射移植修复裸鼠急性肾小管坏死[J].第二军医大学学报,2009,30(6):668-671.

[43]徐璐,廖德怀,陈正,马俊杰,李光辉,方佳丽,等.肾移植中经移植肾动脉输注骨髓间充质干细胞3例报告[J].中国组织工程研究与临床康复,2010,(53):10049-10052.

[44]董晨,杨焕丹,丰炳峰,关凤军,赵彤.骨髓间充质干细胞对阿霉素肾病大鼠肾脏nephrin表达的影响[J].中国组织工程研究与临床康复,2010,14(32):5897-5902.

[45]凌斌,陈静,王廷华,潘兴华,孙洁.骨髓间充质干细胞移植下调MODS兔心、脾、肾组织中细胞凋亡因子Apaf-1 mRNA表达[J].昆明医学院学报,2010,31(3):14-20.

[46]Yoo JH, Park C, Jung DI, Lim CY, Kang BT, Kim JH, et al. In vivo cell tracking of canine allogenic mesenchymal stem cells administration via renal arterial catheterization and physiopathological effects on the kidney in two healthy dogs[J]. J Vet Med Sci, 2011, 73(2):268-274.

[47]Kunter U, Rong S, Djuric Z, Boor P, Muller-Newen G, Yu D, et al. Transplanted mesenchymal stem cells accelerate glomerular healing in experimental glomerulonephritis[J]. J Am Soc Nephrol, 2006, 17(8): 22022212.

[48]李芳,胡祥,赵红梅,贾丹兵,党智杰.人脐带间充质干细胞不同输注途径对急性肾小管坏死的影响[J].中国组织工程研究与临床康复, 2010,14(40):7470-7473.

[49]Herrera MB, Bussolati B, Bruno S, Fonsato V, Romanazzi GM, Camussi G. Mesenchymal stem cells contribute to the renal repair of acute tubular epithelial injury[J]. Int J Mol Med, 2004, 14(6): 1035-1041.

[50]周阳,任野萍.外源性骨髓间充质干细胞在肾脏的分布[J].哈尔滨医科大学学报,2010,44(1):56-59. 
[51]Zhou K, Zhang H, Jin O, Feng X, Yao G, Hou Y, et al. Transplantation of human bone marrow mesenchymal stem cell ameliorates the autoimmune pathogenesis in MRL/lpr mice[J]. Cell Mol Immunol, 2008, 5(6): 417-424.

[52]Togel F, Cohen A, Zhang P, Yang Y, Hu Z, Westenfelder C. Autologous and allogeneic marrow stromal cells are safe and effective for the treatment of acute kidney injury[J]. Stem Cells Dev, 2009, 18(3): 475-485.

[53]Choi S, Park M, Kim J, Hwang S, Park S, Lee Y. The role of mesenchymal stem cells in the functional improvement of chronic renal failure[J]. Stem Cells Dev, 2009, 18(3): 521-529.

[54]Ezquer FE, Ezquer ME, Parrau DB, Carpio D, Yanez AJ, Conget PA. Systemic administration of multipotent mesenchymal stromal cells reverts hyperglycemia and prevents nephropathy in type 1 diabetic mice[J]. Biol Blood Marrow Transplant, 2008, 14(6): 631-640.

[55]Devine SM, Bartholomew AM, Mahmud N, Nelson M, Patil S, Hardy W, et al. Mesenchymal stem cells are capable of homing to the bone marrow of nonhuman primates following systemic infusion[J]. Exp Hematol, 2001, 29(2): 244-255.

[56]Behr L, Hekmati M, Lucchini A, Houcinet K, Faussat AM, Borenstein N, et al. Evaluation of the effect of autologous mesenchymal stem cell injection in a large-animal model of bilateral kidney ischaemia reperfusion injury[J]. Cell Prolif, 2009, 42(3): 284-297.

[57]Koc ON, Gerson SL, Cooper BW, Dyhouse SM, Haynesworth SE, Caplan AI, et al. Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and cultureexpanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy[J]. J Clin Oncol, 2000, 18(2): 307-316.

[58]张学峰,张美荣,胡建霞,王丽,张桂芝,邵磊,等.异种脐带间充质干细胞静脉应用的安全性[J].中国组织工程研究与临床康复,2010,14(32):5971-5975.

[59]Bentzon JF, Stenderup K, Hansen FD, Schroder HD, Abdallah BM, Jensen TG, et al. Tissue distribution and engraftment of human mesenchymal stem cells immortalized by human telomerase reverse transcriptase gene[J]. Biochem Biophys Res Commun, 2005, 330(3): 633-640.

[60]Zhang W, Qin C, Zhou ZM. Mesenchymal stem cells modulate immune responses combined with cyclosporine in a rat renal transplantation model[J]. Transplant Proc, 2007, 39(10): 3404-3408.

[61]Semedo P, Correa-Costa M, Antonio Cenedeze M, Maria Avancini Costa Malheiros D, Antonia dos Reis M, Shimizu MH, et al. Mesenchymal stem cells attenuate renal fibrosis through immune modulation and remodeling properties in a rat remnant kidney model[J]. Stem Cells, 2009, 27(12): 3063-3073.

[62]Herrera MB, Bussolati B, Bruno S, Morando L, Mauriello-Romanazzi G, Sanavio F, et al. Exogenous mesenchymal stem cells localize to the kidney by means of CD44 following acute tubular injury[J]. Kidney Int, 2007, 72(4): 430-441.

[63]Humphreys BD, Bonventre JV. Mesenchymal stem cells in acute kidney injury[J]. Annu Rev Med, 2008, 59: 311-325.

[64]郭琦,万建新,梁萌.急性肾损伤微环境上调骨髓间充质干细胞分泌肾脏保护性生长因子[J].中国中西医结合肾病杂志,2009,10(6):494-497.

[65]刘奎利,刘德忠,金建刚,李海斌,史迎昌,黎立,等.异体脐带间充质干细胞对大鼠心脏移植的免疫调节[J].中国组织工程研究与临床康复,2010,14(6):1048-1052.

PDF(969 KB)

Accesses

Citation

Detail

段落导航
相关文章

/